Elsevier

The Lancet

Volume 342, Issue 8879, 30 October 1993, Pages 1085-1086
The Lancet

Short reports
Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

https://doi.org/10.1016/0140-6736(93)92064-ZGet rights and content

Abstract

We determined the distribution frequency of angiotensin converting enzyme (ACE) polymorphism in 100 patients with hypertrophic cardiomyopathy and 106 of their unaffected siblings and offspring. The distribution of ACE genotypes was different in the two groups: allele D frequency of 0·69 in patients and 0·57 in relatives (p=0·021). The frequency of allele D was also higher in hypertrophic cardiomyopathy families with a high incidence of sudden cardiac death than those with a low incidence (0·74 vs 0·55, p=0·011). In 25 hypertrophic cardiomyopathy patients with a strong family history of sudden cardiac the frequency of allele D was 0·82 (p=0·001 vs normals). Lancet 1993; 342: 1085–86

References (10)

  • B. Rigat et al.

    PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

    Nucleic Acids Res

    (1992)
  • B. Rigat et al.

    An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

    J Clin Invest

    (1990)
  • H. Schunkert et al.

    Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts

    Circulation

    (1993)
  • Jf Hejtmancik et al.

    Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population

    Circulation

    (1991)
There are more references available in the full text version of this article.

Cited by (387)

  • Hypertrophic Cardiomyopathy

    2020, Diastology: Clinical Approach to Heart Failure with Preserved Ejection Fraction
  • Insertion/deletion polymorphism of ACE gene in females with peripartum cardiomyopathy: A case-control study

    2018, Indian Heart Journal
    Citation Excerpt :

    Subjects were categorized as follows on the basis of echocardiographic parameters: Mild LV dysfunction, EF = 41–45, moderate LV dysfunction, EF = 31–40 and severe LV dysfunction, EF ≤ 30. Furthermore, subjects were classified on the basis of severity of LV dilatation as follows: Normal LV end diastolic volume = 56–104 ml; Mild LV dilatation LVEDV, 105–117 ml; Moderate LV dilatation LVEDV, 118–130 ml; and Severe LV dilatation; LVEDV > 130.14 Blood samples were taken from both the groups after obtaining written informed consent.

  • Clinical Applications for Next Generation Sequencing in Cardiology

    2016, Clinical Applications for Next-Generation Sequencing
View all citing articles on Scopus
View full text